期刊文献+

前列腺素E_2对结肠癌细胞CacyBP/SIP核转位的影响 被引量:4

Study on the effect of Prostaglandin E_2 on nuclear translocation of CacyBP/SIP
暂未订购
导出
摘要 目的用前列腺素E2刺激结肠癌细胞,观察和探讨可否引起CacyBP/SIP核转位。方法根据hCacyBP/SIP序列设计引物,PCR扩增、酶切、连接、转化等分子克隆法构建含有钙周期素结合蛋白(CacyBP/SIP)的慢病毒重组质粒,PCR鉴定、测序;将构建好的带有绿荧光蛋白的CacyBP-Lentivirus载体转染至结肠癌SW480细胞,用激光共聚焦显微镜检测CacyBP/SIP表达定位;前列腺素E2刺激后激光共聚焦显微镜、Western blot观察CacyBP/SIP在细胞中的定位。结果激光共聚焦和Westernblot发现:前列腺素E2刺激前CacyBP/SIP定位和表达主要在细胞胞质,用100μmol/L前列腺素E2刺激1h,CacyBP/SIP定位和表达在细胞胞质和胞核。结论前列腺素E2刺激可以引起CacyBP/SIP由胞质转位至细胞核。 Objective To observe and evaluate effect of Prostaglandin E2 on nuclear translocation of CacyBP/SIP by stimulating colorectal cancer with Prostaglandin E2. Methods To design the primer according to the sequenceh of CacyBP/SIP,and to build lentivirus recombinant plasmid contains CacyBP/SIP by cloning. To transfect the over expressed lentiviral vector with Green fluo- rescent protein CacyBP/SIP into 8W480 colon cancer cells, and to test the location and expression of the CacyBP/SIP with Laser Scanning Confocal Microscope and the Western blot. To test the location of the CacyBP/SIP after the stimulation of Prostaglandin E2 with Laser Scanning Confocal Microscope and the Western blot. Results CacyBP/SIP were located and expressed in the periplasm,and both in periplasm and nuclear after 1 hour stimulation of 100 μmol/L Prostaglandin E2 with Laser Scanning Confocal Microscope and Western blot. Conclusion The Prostaglandin E2 can transfer CacyBP/SIP to the nucleus.
出处 《重庆医学》 CAS CSCD 北大核心 2012年第29期3020-3022,共3页 Chongqing medicine
基金 国家自然科学基金资助项目(81072040)
关键词 CacyBP/SIP 前列腺素E类 核转位 结肠肿瘤 CacyBP/SIP prostaglandins E nuclear translocation colonic neoplasms
  • 相关文献

参考文献5

二级参考文献39

  • 1许东奎,陈正煊,薛洪千,张杰峰.PGE_2和IL-2/IL-2R在胃癌患者手术前后的动态变化和相互关系[J].中国胃肠外科杂志,1999,2(2):114-116. 被引量:1
  • 2宁晓暄,孙世仁,李源,龚卫琴,刘理礼,孙力,梁洁,潘阳林,程翌,吴开春,樊代明.钙周期素结合蛋白对胃癌细胞生长增殖的影响[J].中华医学杂志,2006,86(46):3264-3268. 被引量:1
  • 3Shi Y, Hu W, Yin F, et al. Regulation of drug sensitivity of gastric cancer cells by human ealeyelin-binding protein (CaeyBP) [J]. Gastric Cancer,2004, 7 : 160 - 166.
  • 4Zhai H, Shi Y, Yu J, et al . Establishment and characterization of calcyclin binding protein(CacyBP) monoclonal antibody [ J]. Hybridoma ( Larchmt), 2006, 25 ( 2 ) : 91 - 94.
  • 5Shimizu M, Saitoh Y. Immunohistochemical staining of Ha-ras oncogene product in normal benign and malignant human pancreatic tissues [ J ]. Hum Pathol, 1990,21 (6) :607 - 612.
  • 6Filipek A, Wojda U. p30, a novel protein target of mouse calcyclin (S100A6) [ J]. Biochem, 1996,320 (2) :585 - 587.
  • 7Matsuzawa SI, Reed JC. Siah-1, SIP, and Ebi collaborate in a novel pathway for beta-catenin degradation linked to p53 responses [ J ]. Mol Cell,2001, 7:915-926.
  • 8Ning X, Sun S, Hong L, et al. Calcyclin-binding protein inhibits proliferation, tumorigenicity, and invasion of gastric cancer[ J]. Mol Cancer Res, 2007,5 ( 12 ) : 1254 - 1262.
  • 9Sun S, Ning X, Liu J, et al. Overexpressed CacyBP/SIP leads to the suppression of growth in renal cell carcinoma [ J]. Biochem Biophys Res Comm,2007, 356:864 - 871.
  • 10Akenaga K, Nakamura Y, Sakiyama S. Expression of antisense RNA to S100A4 gene encoding an S1002related calcium-binding protein suppresses metastatic potential of high metastatic Lewis lung carcinoma cells[J] . Oncogene ,1997, 14(3) :331 -337.

共引文献24

同被引文献46

  • 1Keiichi I. Nakayama,Keiko Nakayama.Regulation of the cell cycle by SCF-type ubiquitin ligases[J].Seminars in Cell and Developmental Biology.2005(3)
  • 2Ningju Wang,Qingyong Ma,Yinna Wang,Gang Ma,Huihong Zhai.CacyBP/SIP Expression is Involved in the Clinical Progression of Breast Cancer[J].World Journal of Surgery.2010(11)
  • 3Shiren Sun,Xiaoxuan Ning,Jie Liu,Lili Liu,Yu Chen,Shuang Han,Yanqi Zhang,Jie Liang,Kaichun Wu,Daiming Fan.Overexpressed CacyBP/SIP leads to the suppression of growth in renal cell carcinoma[J].Biochemical and Biophysical Research Communications.2007(4)
  • 4Toru Fukushima,Juan M. Zapata,Netai C. Singha,Michael Thomas,Christina L. Kress,Maryla Krajewska,Stan Krajewski,Ze’ev Ronai,John C. Reed,Shu-ichi Matsuzawa.Critical Function for SIP, a Ubiquitin E3 Ligase Component of the β-Catenin Degradation Pathway, for Thymocyte Development and G1 Checkpoint[J].Immunity.2006(1)
  • 5Yongquan Shi,Wenhua Hu,Fang Yin,Li Sun,Changjiang Liu,Mei Lan,Daiming Fan.Regulation of drug sensitivity of gastric cancer cells by human calcyclin-binding protein (CacyBP)[J].Gastric Cancer.2004(3)
  • 6Shu-ichi Matsuzawa,John C. Reed.Siah-1, SIP, and Ebi Collaborate in a Novel Pathway for β-Catenin Degradation Linked to p53 Responses[J].Molecular Cell.2001(5)
  • 7Keiichi I. Nakayama,Keiko Nakayama.Ubiquitin ligases: cell-cycle control and cancer. Nature Reviews Cancer . 2006
  • 8Carrano AC,Eytan E,Hershko A,et al.SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nature Cell Biology . 1999
  • 9M Pagano,SW Tam,AM Theodoras,P Beer-Romero,G Del Sal,V Chau,PR Yew,GF Draetta,M Rol.Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science . 1995
  • 10Charles H. Spruck,Kwang-Ai Won,Steven I. Reed.Deregulated cyclin E induces chromosome instability. Nature . 1999

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部